Search

everythinglearnresearchcommunity

for

Search:↓

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.

Early diagnosis and personalized treatment are crucial for managing hair loss in India.

Changing six essential health practices can help prevent excessive hair shedding.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Hair loss increases between July and October, possibly due to UV light, and factors like skin type, hair color, and density may affect this. Dandruff can worsen hair loss conditions.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

UV rays can cause a type of hair loss known as telogen alopecia.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

The drug Albendazole, used for treating parasites, can cause sudden hair loss.

Low vitamin D levels may cause hair loss in women.

Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Lithium can treat bipolar disorder but may cause hair loss and other hair problems.

Research on hair disorders has advanced, with promising future progress in understanding and treating these conditions.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.